Top 10 Biotechnology Angel Investors in Belgium in January 2026
A list of 10 angel investors that invest in Biotechnology startups based in Belgium. We rank investors based on the number of investments they made in Biotechnology companies from Belgium. We update this investor list every month.Top 10 Biotechnology Angel Investors in Belgium in January 2026
| Investor | Biotechnology Belgium investments |
|---|---|
| Pierre Drion | 3 |
| Annie Vereecken | 3 |
| Luc Vauterin | 2 |
| Herman Verrelst | 1 |
| Evren Ucok | 1 |
| Jean Dessain | 1 |
| Yves Beudin | 1 |
| Virginie Saverys | 1 |
| Patrick Keereman | 1 |
| Kenneth Buckfire | 1 |
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
Impact
Climate
Proptech
Google
Biotech
Health Care
EdTech
Sustainability
Venture Capital
Clean Energy
Web3
Organic Food
Big Data
Video Games
Publishing
Art
B2B
Wellness
Android
Food and Beverage
Digital Media
Payments
Manufacturing
Construction
Real Estate
Finance
Sports
Education
Franchise
Financial Services
eSports
Retail
Mobile
Enterprise Software
Infrastructure
Music
Beauty
Email
Social Media
Photography
Social Network
Biotechnology
Medical
Travel
Legal
Fitness
Local
Internet
Recruiting
Automotive
Social
Hospitality
Wine And Spirits
Medical Device
Mobile Advertising
Crowdfunding
CleanTech
Platforms
Mobile Apps
Cannabis
Transportation
InsurTech
Enterprise
LGBT
Oil and Gas
Fashion
Non Profit
Film
Life Science
Theatre
SaaS
Renewable Energy
Sporting Goods
Restaurants
Software
Celebrity
Social Impact
Cryptocurrency
Agriculture (agtech)
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Australia
Middle East
Indonesia
South Africa
Sri Lanka
Vietnam
Europe
Qatar
Japan
Singapore
Spain
Ghana
China
Egypt
Armenia
Belarus
Hungary
Saudi Arabia
Finland
Oceania
France
Croatia
Africa
Gibraltar
Barbados
Georgia
Greece
LATAM
Czech Republic
Asia
Faroe Islands
Costa Rica
Hong Kong
Brazil
Bahrain
Liechtenstein
Belgium
Panama
Denmark
Bermuda
Estonia
Myanmar
Algeria
Ecuador
Lithuania
Bulgaria
Belize
Chile
Malaysia
Ethiopia
Togo
Rwanda
Slovenia
Poland
Uganda
San Marino
Sweden
Peru
Serbia
Sierra Leone
Thailand
Tanzania
Liberia
Uzbekistan
Zambia
Jersey
Turkey
Lebanon
Uruguay
Tajikistan
Russian Federation
Norway
Portugal
El Salvador
Puerto Rico
Senegal
Zimbabwe
Tunisia
Venezuela
Mexico
Ukraine
Taiwan
Dominican Republic
Italy
Bahamas
Iraq
Iceland
Azerbaijan
Nigeria
Namibia
Mali
United Arab Emirates
Jamaica
Honduras
Philippines
Isle of Man
Bolivia
Luxembourg
Israel
Pakistan
Albania
Kuwait
Mauritius
Malta
Romania
Jordan
Morocco
Grenada
Argentina
Bangladesh
Nicaragua
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Colombia
Cameroon
Austria
Switzerland
Guatemala
Seychelles
Marshall Islands
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Health Care
Biotech
Climate
Community
SaaS
Gaming
Real Estate
Publishing
Retail
Transportation
Payments
Legal
Platforms
Proptech
Hardware
Artificial intelligence
Media (entertainment)
Machine Learning
Construction
Mobile
Consumer
Energy